Search Results - "Rottmann, Antje"

Refine Results
  1. 1
  2. 2

    Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies by Möller, Carsten, Bone, Wilhelm, Cleve, Arwed, Klar, Ulrich, Rotgeri, Andrea, Rottmann, Antje, Schultze‐Mosgau, Marcus‐Hillert, Wagenfeld, Andrea, Schwede, Wolfgang

    Published in ChemMedChem (06-11-2018)
    “…Progesterone plays an important role in the female reproductive system. However, there is also evidence that gynecologic disorders/diseases such as uterine…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The Starch-Related R1 Protein is an α-Glucan, Water Dikinase by Ritte, Gerhard, Lloyd, James R., Eckermann, Nora, Rottmann, Antje, Kossmann, Jens, Steup, Martin

    “…To determine the enzymatic function of the starch-related R1 protein it was heterologously expressed in Escherichia coli and purified to apparent homogeneity…”
    Get full text
    Journal Article
  5. 5

    Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients by JOST, Lorenz M, GSCHWIND, Hans-Peter, MASSON, Eric, LAURENT, Dirk, JALAVA, Tarja, YONGYU WANG, GUENTHER, Clemens, SOUPPART, Claire, ROTTMANN, Antje, DENNER, Karsten, WALDMEIER, Felix, GROSS, Gerhard

    Published in Drug metabolism and disposition (01-11-2006)
    “…Vatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors. Vatalanib is under…”
    Get full text
    Journal Article
  6. 6

    Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults by Hofmann, Birte Maria, Riecke, Kai, Klein, Stefan, Berse, Matthias, Rottmann, Antje, Sutter, Gabriele, Ebert, Wolfgang

    Published in Investigative radiology (01-02-2024)
    “…Gadolinium (Gd)-based contrast agents are well established in clinical routine and have been proven safe and effective. However, there is a need for…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Quantitative Systems Toxicology Identifies Independent Mechanisms for Hepatotoxicity and Bilirubin Elevations Due to AKR1C3 Inhibitor BAY1128688 by Battista, Christina, Shoda, Lisl K.M., Watkins, Paul B., Groettrup‐Wolfers, Esther, Rottmann, Antje, Raschke, Marian, Generaux, Grant T.

    Published in Clinical pharmacology and therapeutics (01-11-2023)
    “…BAY1128688 is a selective inhibitor of AKR1C3, investigated recently in a trial that was prematurely terminated due to drug‐induced liver injury. These…”
    Get full text
    Journal Article
  9. 9

    Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview by Schultze-Mosgau, Marcus-Hillert, Ploeger, Bart A., Frei, Matthias, Höchel, Joachim, Rottmann, Antje

    Published in Clinical pharmacokinetics (01-01-2022)
    “…Vilaprisan is a highly potent selective progesterone receptor modulator in development for the treatment of symptomatic uterine fibroids and endometriosis. Its…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential by Schultze-Mosgau, Marcus-Hillert, Höchel, Joachim, Prien, Olaf, Zimmermann, Torsten, Brooks, Ashley, Bush, Jim, Rottmann, Antje

    Published in Clinical pharmacokinetics (01-08-2018)
    “…Background and objectives In-vitro data suggest that clearance of vilaprisan is mediated by cytochrome P450 3A4 (oxidation) and aldoketoreductases (reduction)…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate by Berger, Markus, May, Ekkehard, Rehwinkel, Hartmut, Schäcke, Heike, Neuhaus, Roland, Rottmann, Antje, Zollner, Thomas M., Jaroch, Stefan

    Published in Bioorganic & medicinal chemistry letters (15-08-2020)
    “…[Display omitted] We report on the discovery of the new clinical candidate BAY 1003803 as glucocorticoid receptor agonist for the topical treatment of…”
    Get full text
    Journal Article
  15. 15

    Mass Balance and Metabolic Pathways of Eliapixant, a P2X3 Receptor Antagonist, in Healthy Male Volunteers by Reif, Stefanie, Schultze-Mosgau, Marcus-Hillert, Engelen, Anna, Piel, Isabel, Denner, Karsten, Roffel, Ad, Tiessen, Renger, Klein, Stefan, Francke, Klaus, Rottmann, Antje

    “…Background Overactive adenosine triphosphate signaling via P2X3 homotrimeric receptors is implicated in multiple conditions. To fully understand the metabolism…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Front Cover: Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies (ChemMedChem 21/2018) by Möller, Carsten, Bone, Wilhelm, Cleve, Arwed, Klar, Ulrich, Rotgeri, Andrea, Rottmann, Antje, Schultze‐Mosgau, Marcus‐Hillert, Wagenfeld, Andrea, Schwede, Wolfgang

    Published in ChemMedChem (06-11-2018)
    “…The Front Cover shows vilaprisan, a highly selective progesterone receptor modulator (SPRM), bound to the progesterone receptor (PR). Gynecologic diseases such…”
    Get full text
    Journal Article
  19. 19

    Determination of rat serum esterase activities by an HPLC method using S-acetylthiocholine iodide and p-nitrophenyl acetate by Koitka, Matthias, Höchel, Joachim, Obst, Detlev, Rottmann, Antje, Gieschen, Hille, Borchert, Hans-Hubert

    Published in Analytical biochemistry (01-10-2008)
    “…Establishing esterase assays allows the determination and comparison of esteratic activities of tissues of one organism and between organisms. We have…”
    Get full text
    Journal Article
  20. 20